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aDepartment of Radiology, Philipps University, Marburg, Germany
bDepartment of Medical Biometry and Epidemiology, Philipps University, Marburg, GermanyAbstractPurpose: To assess the occurrence and positive predictive value of additional nonmass findings to stratify the risk of breast
microcalcifications.
Methods: This retrospective evaluation included 278 lesions with vacuum- or image-guided hook-wire biopsy for suspicious micro-
calcifications. The lesions were categorized into exclusive microcalcifications and microcalcifications with focal asymmetry, tubular density
or architectural distortion (ie, nonmass findings). To evaluate the utility of additional nonmass findings for risk stratification, outcome
variables were positive predictive values and odds ratios for malignancy and invasive carcinoma.
Results: Forty-five of 278 microcalcification lesions (16%) were associated with nonmass findings: 28 focal asymmetries, 2 tubular densities,
and 15 focal asymmetries in conjunction with tubular densities. Architectural distortion was observed in 28 of these cases. The odds ratio for
additional nonmass findings relative to exclusive microcalcifications was 5.9 and was statistically significant (P < .00001). Architectural
distortion was the most specific indicator for malignancy and invasiveness, with odds ratios of 6.5 (P ¼ .0072) and 5.6 (P ¼ .0214),
respectively.
Conclusions: Microcalcifications with nonmass findings were less frequent than exclusive microcalcifications but were more predictive for
malignancy. Architectural distortion demonstrated the highest risk of malignancy and invasiveness. Assessment of additional nonmass
findings might be useful for further risk stratification of microcalcifications, indications for additional imaging, and pretreatment
considerations.ResumeObjet : Evaluer la frequence et la valeur predictive positive des resultats supplementaires de rehaussement sans masse afin de stratifier les
risques de microcalcifications mammaires.
Methodes : L’evaluation retrospective englobait 278 lesions ayant fait l’objet d’une biopsie pour des microcalcifications suspectes, soit par
aspiration, soit suite a la mise en place d’un harpon stereoguide. Les lesions ont ete classifiees en microcalcifications isolees et en micro-
calcifications avec asymetrie focale, densite tubulaire ou distorsion architecturale (c.-a-d. rehaussement sans masse). Dans le but de mesurer
l’utilite des resultats supplementaires de rehaussement sans masse a des fins de stratification des risques, les resultats ont ete etablis comme
valeurs predictives positives et comme rapports de cotes de la malignite et du carcinome invasif.
Resultats : Parmi les 278 lesions presentant des microcalcifications, 45 (16%) etaient associees a un rehaussement sans masse, dont 28 cas
d’asymetrie focale, 2 cas de densite tubulaire et 15 cas d’asymetrie focale assortie de densite tubulaire. Une distorsion architecturale a ete
observee dans 28 de ces cas. Le rapport de cotes pour les resultats supplementaires de rehaussement sans masse par rapport aux
microcalcifications isolees etait de 5,9 et etait statistiquement significatif (P < 0,00001). La distorsion architecturale s’est averee
l’indicateur de malignite ou de cancer invasif le plus precis, presentant un rapport de cote de 6,5 (P ¼ 0,0072) et de 5,6 (P ¼ 0,0214),
respectivement.
Conclusions : Les microcalcifications presentant un rehaussement sans masse etaient moins frequentes que les microcalcifications isolees,
mais detenaient une valeur predictive plus elevee au chapitre de la malignite. La distorsion architecturale a par ailleurs demontre le risque de
malignite ou de cancer invasif le plus eleve. L’evaluation des resultats supplementaires de rehaussement sans masse pourrait servir a stratifier* Address for correspondence: Marga B. Rominger, MD, Department of
Radiology, Philipps University, Baldingerstrasse D-35033, Marburg,
Germany.
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334 M. B. Rominger et al. / Canadian Association of Radiologists Journal 64 (2013) 333e338les risques des microcalcifications de maniere plus exhaustive, a indiquer le besoin d’examens supplementaires et a analyser les diverses
considerations entourant le pretraitement.
 2013 Canadian Association of Radiologists. All rights reserved.
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are generally used for risk stratification of breast malignancy
[1]. The use of focal asymmetry, tubular density, and archi-
tectural distortion in the context of microcalcifications for
risk stratification has received less attention. Studies of
proven ductal carcinoma in situ (DCIS) alone are reporting
the occurrence of focal asymmetry and architectural distor-
tion in conjunction with DCIS [2,3]. Stomper et al [3] found
that the spectrum of soft-tissue abnormalities associated with
clinically occult DCIS appears to have 2 major pathologic
correlations: a direct manifestation of the tumour with
tumour-filled ducts and the presence of periductal fibrosis or
elastosis, which creates an irregular or spiculated mass. By
using subgross histology and large-section histology, Tabar
et al [4] explained tumour-forming DCIS by the induction of
dense and disorganized duct-like structures. The presence of
a basement membrane classifies these structures as an in situ
process.
In a large study, Venkatesan et al [5] examined the posi-
tive predictive value of specific mammographic findings.
Focal asymmetry exhibited the lowest predictive value for
malignancy. Architectural distortion demonstrated a low
prevalence but was highly predictive of invasive cancer.
Calcifications were similarly predictive of invasive cancer
and DCIS in their cohort. Combinations of mammographic
findings were not analysed in this study. If associated with
suspicious microcalcifications, then tubular structures were
considered significant by the standards presented by the
American College of Radiology Breast Imaging-Reporting
and Data System (BI-RADS), 4th edition, [1]. We noticed
a lack of studies that quantify the positive predictive value
for malignancy of suspicious microcalcifications in
conjunction with nonmass findings: focal asymmetry, tubular
density, and architectural distortion. Therefore, we evaluated
the occurrence and positive predictive value for malignancy
and invasiveness of suspicious microcalcifications with and
without additional nonmass findings.
Materials and MethodsStudy DesignThis retrospective study includes the results of 324
consecutive x-rayeguided biopsies (vacuum-assisted stereo-
tactic biopsy or open surgery with hook-wire guidance) per-
formed in 284 women because of nonpalpable suspicious
microcalcifications on mammograms between January 2002
and December 2003 at an academic hospital before the intro-
duction of an official and nationwide screening program, andwere part of a 7-year follow-up. The mammograms were
retrospectively reevaluated by 2 subspecialty-trained breast
imagers in accordance (E.V.S., M.B.R.). The readers were
blinded for histopathology, medical record, and previous
description of microcalcifications. The analysis of additional
mammographic findings included focal asymmetry, tubular
density (tubular structure), and architectural distortion [1]. The
exclusion criteria for this retrospective analysis with special
focus on microcalcifications with nonmass lesions were as
follows: (a) microcalcifications were not identified in the
histologic specimen (1 case of vacuum biopsy; all other 108
vacuum biopsies were technically successful), (b) 2 or more
synchronous or asynchronous separate accumulations of
microcalcifications in the same quadrant (1 case of asynchro-
nous microcalcifications in the same quadrant), and (c)
mammographic images that showed a combination of micro-
calcificationswith sphericalmass (44 cases; 9 complex lesions,
and 35 cases selected for x-rayeguided biopsy because of
small, invisible, or not clearly detectable sphericalmass lesions
on prior focused ultrasound). Thus, 278 mammographic
lesions (either pure microcalcifications or microcalcifications
with nonmass findings) were further analysed in regard to the
positive predictive value for malignancy and invasiveness.PatientsThe institutional review board approved this study and
waived the requirement for informed consent. The women
were 25-83 years of age (mean age [SD], 54.5  11.3 years).
All included mammographic lesions were nonpalpable breast
lesions. Twenty-six women with 31 included mammographic
lesions were followed-up because of a history of breast
cancer (prior histologic examination: 4 women with pure
DCIS and 22 women with invasive carcinoma with or
without a DCIS component). Fourteen women (14 lesions, 1
woman with a history of breast cancer) showed a suspicious
palpation within a different quadrant, and 7 women
(7 lesions; 2 women with a history of breast cancer) mani-
fested with nipple discharge. Hence, 3 women had a history
of breast cancer and were symptomatic women. Thus, 229 of
278 mammographic lesions were screen-like detected lesions
in asymptomatic women (206 asymptomatic women without
a history of breast cancer).Mammograms and ReadingsExaminations were made by using the dedicated screen-film
technique. During the 2-year study period, a total of 7878
mammograms were evaluated. Craniocaudal, mediolateral
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tively evaluated.Only imagesobtainedbeforebiopsywereused.
The minimum number of suspicious microcalcifications was
more than 5 per 1 mL, with a maximum size below 1 mm in
width. Focal asymmetry in the context of this study was a dense
structure that was irregular, observed in 2 planes (although
probably less well in 1 of the 2 planes), and more ill defined and
less dense than a sphericalmass.An asymmetry seen in only one
view was considered irrelevant for this study because of the
general workup protocol for microcalcifications of 3 planes and
magnification views. Only tubular, dense structures that point
to and from microcalcifications with or without micro-
calcifications inside were considered as tubular densities.
Architectural distortionwas defined as thin lines or spiculations
that radiated from the microcalcification lesion or within close
vicinity. Type descriptors of suspicious microcalcifications of
intermediate concern were the following: amorphous or indis-
tinct, coarse heterogeneous, and suspicious round or punctate.
Distribution descriptors of lower concern were the following:
clustered, regional, and diffuse. Small lesions were micro-
calcification lesions with less than 2 cm of greatest diameter.BiopsiesOne hundred and eight lesions in 108 patients were
confirmed by vacuum-assisted stereotactic biopsy on
a digital prone table (Mammotest; Fischer Imaging, Denver,
CO) with 11-gauge vacuum probes. One hundred and
seventy lesions in 132 patients were primarily treated by
open surgery. The average time between mammography and
final histologic verification was 20 days (range, 0-217 days).
Radiography was performed for all surgical specimens.
Nowadays, all women with suspicious breast lesions undergo
image-guided percutaneous assessment.Histologic ExaminationHistologic examination was performed in-house, in
accordance with generally accepted histologic standards.
Definitive histologic analysis of the surgical specimens
allowed grouping of the results into 3 classes, according to
the pathology codes of the BI-RADS, 4th edition [1]: benign,
malignant (DCIS and/or invasive carcinoma), and malignant
subgroup invasive (invasive carcinoma only with or without
a DCIS component). Atypical ductal hyperplasia, atypical
lobular hyperplasia, and lobular carcinoma in situ were
classified under the rubric benign lesions. If there were
multiple histologic findings within 1 specimen, then the most
suspicious histopathology was considered to be the final
histologic result.StatisticsFigure 1. A 64-year-old woman with intraductal carcinoma, demonstrating
suspicious microcalcifications with focal asymmetry on the craniocaudal
magnification view of her right breast.For statistical analysis, we used the software R (The R
Project for Statistical Computing, www.r-project.org, version
2.15.0) and Excel (Excel 2000; Microsoft, Redmond, WA).
To calculate the positive predictive value for invasivenessand malignancy, the proportion of invasive or malignant
(DCIS and invasive carcinomas) lesions of all the lesions of
the subtype were considered. For odds ratio calculation,
microcalcifications without additional findings were consid-
ered as the baseline risk group. The difference between
exclusive microcalcifications and additional nonmass find-
ings was tested with the Fisher exact test. To assess the
contribution of each individual additional nonmass finding,
as well as the other risk factors together with additional
nonmass finding, to the risk of malignancy and invasiveness
logistic regression was used. P values less than .05 were
considered statistically significant.
ResultsOccurrence of Microcalcifications With Nonmass
LesionsTwo hundred and thirty-three of 278 lesions (84%) were
pure microcalcifications. The remaining 45 lesions (16%)
exhibited additional nonspherical-mass lesions: 28 focal
asymmetries, 2 tubular densities, and 15 focal asymmetries
in combination with tubular densities. Architectural distor-
tion was identified in 28 of 45 microcalcifications with
associated nonspherical mass lesions (62%): 17 of 28 with
focal asymmetries (61%), 1 of 2 tubular densities (50%), and
10 of 15 focal asymmetries with tubular densities (67%). The
occurrence of microcalcifications with nonmass findings of
clinically asymptomatic, screen-like detected lesions was 33
of 229 mammographic lesions (14%). Two examples of
microcalcifications with additional nonmass findings are
included for illustration (Figures 1 and 2).
Figure 2. A 61-year-old woman with invasive carcinoma, demonstrating
suspicious microcalcifications with focal asymmetry and architectural
distortion in close vicinity on the mediolateral oblique magnification view of
her left breast.
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Invasiveness of Microcalcifications With and Without
Nonmass FindingsFifty-five of 233 exclusive microcalcifications (24%) were
malignant. Twenty-nine of 45 microcalcifications (64%) with
a nonmass finding were malignant, as were 16 of 28
microcalcifications with focal asymmetry (57%) (8 DCIS
and 8 invasive carcinoma), both with tubular density (both
DCIS); 11 of 15 with combined focal asymmetry and tubular
density (73%) (3 DCIS and 8 invasive carcinoma); and 22 of
28 with architectural distortion (79%) (8 DCIS and 14
invasive carcinoma). The respective proportions of DCIS of
malignant cases of the cohort were 63% (53/84), exclusive
microcalcifications 73% (40/55), and microcalcifications
with additional nonmass findings 45% (13/29). The positive
predictive value for malignancy of the subgroup of clinicallyTable 1
Occurrence, positive predictive values, and odds ratios of microcalcifications fo
carcinoma only) with and without additional nonmass findings
Microcalcifications n
No. malignant
lesions
Positive predictive
value for malignancy
% (95% CI)
Pure microcalcifications 233 55 23.6 (18.3-29.6)
Microcalcifications with nonmass
findings
45 29 64.4 (48.8-78.1)
With architectural distortion 28 22 78.6 (59.0-91.7)
Without architectural distortion 17 7 41.2 (18.4-67.1)
CI ¼ confidence interval; DCIS ¼ ductal carcinoma in situ; OR ¼ odds ratio.
a Pure microcalcifications as baseline.asymptomatic, screen-like detected microcalcifications with
additional nonmass findings was 21 of 33 mammographic
lesions (64%) (9 invasive carcinoma, 12 DCIS) and, for
microcalcifications alone, 42 of 196 lesions (21%) (11
invasive carcinoma, 31 DCIS). The positive predictive value
for malignancy of microcalcifications with focal asymmetry
without architectural distortion was 36% (4/11) (2 invasive
cancer and 2 DCIS) and for the subgroup of clinically
asymptomatic, screen-like detected lesions was 30% (3/10)
(1 invasive cancer and 2 DCIS). Positive predictive values
and odds ratios for malignancy and invasiveness of breast
microcalcifications with and without additional nonmass
findings and for subgroups with and without architectural
distortion are listed in detail in Table 1. The respective odds
ratios for malignancy and invasiveness of all micro-
calcification lesions with additional nonmass findings rela-
tive to exclusive microcalcifications were 5.9 and 8.0, and
were statistically significant (P < .00001). Further logistic
regression analysis of the individual nonmass findings
demonstrated significantly increased odds ratios for malig-
nancy and invasiveness in case of architectural distortion
(Table 2). Positive predictive values and odds ratios for
malignancy and invasiveness with and without additional
findings in regard to screen-like detected lesions, type
descriptors of intermediate concern, distribution descriptors,
and size are listed in Table 3. Further logistic regression
analysis showed that nonmass findings are an additional
significant factor for risk stratification of malignancy and
invasiveness, which is independent from the presence of
screening, type, and distribution descriptors as well as size
(both P < .0001) (Table 4).Discussion
Soft-tissue abnormalities were observed by Barreau et al
[2] on the mammograms of 255 of 909 lesions with DCIS
(28%). These included indistinct, well-defined, ill-defined,
and spiculated lesions, focal asymmetry, and architectural
distortion with and without microcalcifications. Stomper et al
[3] studied the surrounding tissue of 100 clinically occult
DCIS lesions detected with mammography: 72% of these
lesions appeared as microcalcifications, 10% as soft-tissue
abnormalities, and 12% as a combination of the two. Tabarr malignancy (DCIS and/or invasive carcinoma) and invasiveness (invasive
, No. invasive
lesions
Positive predictive
value for invasiveness,
% (95% CI)
OR for
malignancy
(95% CI)a
OR for
invasiveness
(95% CI)a
15 6.4 (3.6-10.4) d d
16 35.6 (21.9-51.2) 5.9 (3.0-11.6) 8.0 (3.6-17.9)
14 50.0 (30.6-69.4) 11.9 (4.6-30.7) 14.5 (5.9-36.0)
2 11.8 (1.5-36.4) 2.3 (0.8-6.2) 1.9 (0.4-9.3)
Table 2
Contribution of each individual additional nonmass finding for risk stratifi-
cation of microcalcifications
b OR (95% CI) P value
Risk of malignancy
Focal asymmetry 0.2288 1.26 (0.4-3.8) .6993
Tubular density 1.1334 3.11 (0.8-14.2) .1134
Architectural distortion 1.8768 6.53 (1.8-28.2) .0072
Risk of invasiveness
Focal asymmetry 0.7081 2.0 (0.4-7.8) .3337
Tubular density 0.8060 2.2 (0.6-8.1) .2167
Architectural distortion 1.7220 5.6 (1.4-28.6) .0214
CI ¼ confidence interval; OR ¼ odds ratio.
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subgross and large-section histologic examination, and
explained the presence of focal asymmetry and architectural
distortion with DCIS by using the theory of neoductgenesis.
Focal asymmetry corresponded to unnaturally high concen-
trations of duct-like structures within a limited area. Many of
these were surrounded by desmoplastic reaction and
lymphocytic infiltration. The investigators observed over-
expression of Tenascin C around the newly formed ducts.
Tenascin C is a complex multifunctional protein that
promotes angiogenesis, tumour growth, and invasion [6]. The
theory of neoductgenesis and defect of the basement
membrane is supported by a recent study of magnetic reso-
nance imaging that shows intrusion of gadolinium inside and
along neoplastic mammary ducts in a murine model [7].
In our cohort, which excluded typical mass findings, the
occurrence of microcalcifications with additional nonmass
findings was 16%. Distended ducts with only inside micro-
calcifications were, with 2 cases, a rare finding and specific
for DCIS. The proportion of DCIS of all malignant lesions ofTable 3
Occurrence, positive predictive values, and odds ratios of microcalcifications fo
carcinoma only) without (pure microcalcifications) and with additional nonmass fi
type descriptors (amorphous or indistinct, coarse heterogeneous, and suspicious
diffuse), and small size (<2 cm)
History
Screen-like d
asymptomati
lesions (n ¼
Pure microcalcifications
Total no. 196
No. malignancies 42
Positive predictive value for malignancy, % (95% CI) 21.4 (15.9-2
No. invasive malignancies 11
Positive predictive value for invasive malignancy, % (95% CI) 5.6 (2.8-9.8
Microcalcification lesions with additional nonmass findings
Total no. 33
No. malignancies 21
Positive predictive value for malignancy, % (95% CI) 63.6 (45.1-7
No. invasive malignancies 9
Positive predictive value for invasive malignancy, % (95% CI) 27.3 (13.3-4
OR for malignancy (95% CI)a 6.4 (2.9-14
OR for invasiveness (95% CI)a 6.3 (2.4-16
CI ¼ confidence interval; DCIS ¼ ductal carcinoma in situ; OR ¼ odds ratio.
a Without additional nonmass findings as baseline.our cohort was 63%, which is in the range of other studies
that have excluded typical mass findings from their cohort
[8e11]. The proportion of DCIS of malignant cases of our
study was 73% for microcalcifications alone compared with
45% with associated nonmass findings. One-fourth of all
proven DCIS lesions in this study exhibited a combination of
microcalcifications and nonmass findings. This proportion
was higher, as indicated by previously published studies
[2,3].
This study found a significantly higher positive predictive
value for malignancy of 64% and invasiveness of 36% for all
microcalcifications with additional nonmass findings
compared with exclusive microcalcifications, which had
a positive predictive value for malignancy of only 24% and
invasiveness of 6%. We found that nonmass findings
increased the positive predictive value for malignancy and
invasiveness independent from history, size of lesion, type,
and distribution descriptors. Focal asymmetry was the most
common nonmass finding and was commonly found in
conjunction with other nonmass findings. However, the
positive predictive value for malignancy of micro-
calcifications with focal asymmetry alone was only 36% (for
the subgroup of clinically asymptomatic, screen-like detec-
ted lesions in women, 30%); the odds ratio of logistic
regression was not significantly different from micro-
calcifications alone. The results are in accordance with the
study of Burrell et al [12]. In their cohort, the positive
predictive value for malignancy of microcalcifications alone
(45%) did not vary versus microcalcifications with a density
(44%). However, within their subgroup of screen-detected
lesions, the positive predictive value for malignancy of
microcalcifications with densities was higher than of
microcalcifications alone (67% vs 46%). Tubular denser malignancy (DCIS and/or invasive carcinoma) and invasiveness (invasive
ndings for screen-like detected, asymptomatic lesions, intermediate concern
round/punctate), nonehigh-risk distribution descriptors (clustered, regional,
Microcalcification characteristics
etected,
c
229)
Intermediate
concern type
descriptors (n ¼ 171)
Nonehigh-risk
distribution
descriptors (n ¼ 237)
Small size
(n ¼ 204)
150 197 170
19 41 31
7.8) 12.7 (7.8-19.1) 20.8 (15.4-27.2) 18.2 (12.7-24.9)
7 10 6
) 4.7 (1.9-9.4) 5.1 (2.5-9.1) 3.5 (1.3-7.5)
21 40 34
11 24 22
9.6) 52.4 (29.8-74.3) 60.0 (43.3-75.1) 64.7 (46.5-80.3)
5 12 12
5.5) 23.8 (8.2-47.2) 30.0 (16.6-46.5) 35.3 (19.7-53.5)
.1) 7.6 (2.8-20.3) 5.7 (2.8-11.7) 8.2 (3.7-18.4)
.8) 6.4 (1.8-22.5) 8.0 (3.2-20.3) 14.9 (5.1-43.7)
Table 4
Contribution of each individual risk factor and additional nonmass finding
for risk stratification of microcalcifications
b OR (95% CI) P value
Risk of malignancy
High-risk type descriptora 1.57 4.8 (2.6-8.9) <.0001
High-risk distributionb 1.01 2.7 (0.9-8.3) .0693
Nonescreen-like asymptomaticc 0.90 2.5 (1.2-5.2) .0170
Non-small sized 0.15 1.2 (0.5-2.8) .7431
Additional nonmass finding 1.77 5.9 (2.8-12.7) <.0001
Risk of invasiveness
High-risk type descriptora 0.93 2.5 (1.1-6.3) .0364
High-risk distributionb 1.33 3.8 (0.9-18.1) .0738
Nonescreen-like asymptomaticc 1.34 3.8 (1.5-10.1) .0063
Non-small sized 0.21 1.2 (0.3-4.1) .7436
Additional nonmass finding 2.09 8.0 (3.4-20.0) <.0001
CI ¼ confidence interval; OR ¼ odds ratio.
a Fine pleomorphic, and fine linear or fine-linear branching.
b Segmental and linear.
c History of breast cancer or symptomatic woman.
d Size  2 cm.
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neoduct- or neoangiogenesis. Logistic regression analysis
found significantly increased odds ratio of micro-
calcifications in conjunction with tubular densities for
malignancy. The most important predictor for malignancy
and invasiveness of microcalcifications was architectural
distortion, which is in line with the study by Venkatesan et al
[5] that examined single mammographic findings and found
architectural distortion to be the most indicative predictor for
malignancy and invasiveness.
To our knowledge, this is the first study to provide
detailed results of the frequency of occurrence, positive
predictive value for malignancy, and invasiveness of micro-
calcifications with associated focal asymmetry, tubular
density, and architectural distortion. Type and distribution
descriptors of microcalcifications stratify the risk of malig-
nancy; however, they lack the ability to stratify the risk for
invasiveness [8,11,13]. The assessment of additional non-
mass findings might be helpful for further risk stratification
of microcalcifications, an indication for additional imaging,
and pretreatment considerations. There were several limita-
tions to this study. Challenging interobserver, intraobserver,
and interinstitution variabilities are inherent to all mammo-
graphic descriptors. Gross pathology (for the exact correla-
tion of additional nonmass findings with histopathology) was
unavailable to our institution. The cohort was based on
screen-film mammography, and digital mammography might
be more accurate [14]. Therefore, our results must be
confirmed by others, and further research is encouraged.In conclusion, this study found that breast micro-
calcifications in conjunction with nonmass lesions were an
infrequent mammographic finding. Compared with pure
microcalcifications, the presence of additional nonmass
findings significantly increased the risk for malignancy in
microcalcification lesions. The most important predictor of
malignancy and invasiveness was architectural distortion.References
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